Cynthia Seidel-Dugan

2022

In 2022, Cynthia Seidel-Dugan earned a total compensation of $1.2M as Chief Scientific Officer at Werewolf Therapeutics, a 2% increase compared to previous year.

Compensation breakdown

Bonus$172,724
Option Awards$610,524
Salary$416,000
Other$11,630
Total$1,210,878

Seidel-Dugan received $610.5K in option awards, accounting for 50% of the total pay in 2022.

Seidel-Dugan also received $172.7K in bonus, $416K in salary and $11.6K in other compensation.

Rankings

In 2022, Cynthia Seidel-Dugan's compensation ranked 2,654th out of 5,753 executives tracked by ExecPay. In other words, Seidel-Dugan earned more than 53.9% of executives.

ClassificationRankingPercentile
All
2,654
out of 5,753
54th
Division
Manufacturing
1,476
out of 3,133
53rd
Major group
Chemicals And Allied Products
677
out of 1,419
52nd
Industry group
Drugs
630
out of 1,320
52nd
Industry
Pharmaceutical Preparations
454
out of 966
53rd
Source: SEC filing on April 27, 2023.

Seidel-Dugan's colleagues

We found three more compensation records of executives who worked with Cynthia Seidel-Dugan at Werewolf Therapeutics in 2022.

2022

Daniel Hicklin

Werewolf Therapeutics

Chief Executive Officer

2022

Randi Isaacs

Werewolf Therapeutics

Chief Medical Officer

2022

Timothy Trost

Werewolf Therapeutics

Chief Financial Officer

News

In-depth

You may also like